Firms Seek OK of Drug for Pancreatic Cancer
- Share via
From Bloomberg News
Swiss firm Roche Holding and partners Genentech Inc. of South San Francisco and OSI Pharmaceuticals Inc. of Melville, N.Y., have asked U.S. regulators to approve the lung cancer drug Tarceva to treat pancreatic cancer.
The three companies submitted an application to the Food and Drug Administration for the new use after a study showed that the drug helped patients live longer when taken with chemotherapy, Roche said.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
